Patterns and Gender-Specific Prevalence of Obesity and Severe Obesity Among Hospitalized Adults in the United States, 2012–2021
Overview
This study analyzes hospital-coded obesity rates in the U.S. from 2012 to 2021, revealing significant trends in obesity and severe obesity prevalence among hospitalized adults. It highlights notable gender-specific differences and demographic variations that could inform targeted interventions.
Background
Obesity is a growing public health concern in the U.S., contributing to increased morbidity and healthcare costs. Understanding the prevalence of obesity in hospitalized patients is crucial, as it often complicates clinical management and resource utilization. This study aims to fill the gap in knowledge regarding hospital burden and demographic differences in obesity rates.
Data Highlights
Remove the statement about no numerical data; include key statistics if available.
Key Findings
Hospital-coded obesity rates were analyzed from 2012 to 2021 using the National Inpatient Sample.
Obesity is a common comorbidity in hospitalized patients, influencing clinical management and outcomes.
Gender-specific differences in obesity prevalence were observed, with implications for healthcare utilization.
Demographic factors such as age, race/ethnicity, and urban-rural residence were considered in the analysis.
Obesity rates are often underrecognized or inconsistently documented during hospitalizations.
Clinical Implications
Healthcare providers should be aware of the high prevalence of obesity among hospitalized patients and the associated challenges in management. Improved documentation and recognition of obesity as a comorbidity can enhance clinical outcomes and resource allocation. Targeted interventions may be necessary to address the specific needs of different demographic groups.
Conclusion
The rising prevalence of obesity among hospitalized adults underscores the need for enhanced awareness and tailored interventions. Understanding demographic variations can guide future healthcare strategies.
by Jacob Lui, Karen M. Fischer, Ruchi Gupta, Abhinav Singla, Aleksandra Murawska Baptista, Dominique Monlezun, Shant Ayanian, Cheˈ Matthew Harris, Sagar B. Dugani
A posthoc analysis of a phase 2b trial found favorable changes in DNA methylation–based aging biomarkers among patients with human immunodeficiency virus–associated lipohypertrophy.
